Island Pharmaceuticals Ltd ILPLF
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 295.92M
- Market Cap
- —
- Volume/Avg
- 20,500 / 20,500
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Island Pharmaceuticals Ltd is a drug research and repurposing company focused on developing preventative or therapeutic drugs for viral infections, public health, or biosecurity threats. The company is following a dual development plan for its assets, ISLA-101 and Galidesivir. Its product candidate, ISLA-101, is being repurposed for the prevention and treatment of dengue fever and other mosquito-borne (or vector) borne diseases. Galidesivir is a clinical-stage antiviral molecule with a broad spectrum of activity in over 20 RNA viruses, including high-priority threats such as Ebola, Marburg, MERS, Zika, and Yellow fever viruses, with unmet medical needs. The company operates in a single segment, being research and development activities in Australia and the United States of America.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
Valuation
|
Metric
|
ILPLF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ILPLF
|
|---|---|
Quick Ratio | 8.40 |
Current Ratio | 8.40 |
Interest Coverage | — |
Quick Ratio
ILPLF
Profitability
|
Metric
|
ILPLF
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
ILPLF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>jK#K!f | LOCK|>DWS | $126B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|gNS!<l | LOCK|HPSg | $81B | |||
| argenx SE ADR
ARGX
| LOCK|Bj<nn> | LOCK|J^g | $55B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|<%v!#dd | LOCK|HTyr | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|@^d!F!! | LOCK|!> | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|HXxzG# | LOCK|!thrW | $29B | |||
| Incyte Corp
INCY
| LOCK|D<bBTZv | LOCK|$G | $24B | |||
| Moderna Inc
MRNA
| LOCK|L?%hWC | LOCK|J@ | $24B | |||
| BioNTech SE ADR
BNTX
| LOCK|%>@GBHQ | LOCK|>N | $24B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|%vW&mby | LOCK|p! | $17B |
United States